Publications

• Optimizing culture-free approaches to recover high quality M. tuberculosis genomic variation.Walter KS, Dos Santos PCP, Carey A, Shakir SM, Colijn C, Cohen T, Mathema B, Croda J, Andrews JR. medRxiv. 2025 Dec 18; 2025 Dec 18. PMID: 41445623.
• Systematic differences in TB treatment outcomes across Brazil by patient- and area-related factors: an analysis of national disease registry data.Ryuk DK, Pelissari DM, Alves K, Harada LO, Oliveira PB, Johansen FDC, Maciel ELN, Castro MC, Cohen T, Sanchez M, Menzies NA. BMJ Glob Health. 2025 Dec 5; 2025 Dec 5. PMID: 41360481.
• Potential paediatric tuberculosis incidence and deaths resulting from interruption in programmes supported by international health aid, 2025-34: a mathematical modelling study.Menzies NA, Brown TS, Imai-Eaton JW, Dodd PJ, Cohen T, Martinez L. Lancet Child Adolesc Health. 2025 Nov; 2025 Sep 12. PMID: 40953585.
• Transmission of Bedaquiline-resistant Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.Sobol R, Omar SV, Brown T, Joseph L, Lutchminarian K, Tang L, Lan Y, Willis F, Campbell A, Warren JL, Cohen T, Brust JCM, Naidoo K, Shah NS, Gandhi NR, Mathema B. Am J Respir Crit Care Med. 2025 Sep 30; 2025 Sep 30. PMID: 41026808.
• Comparison of phylogenetic metrics of transmission in symptomatic and asymptomatic tuberculosis.Da Silva KE, Dos Santos PCP, Tsuha DH, Walter KS, Cunha EAT, Colijn C, Cohen T, de Oliveira RD, Bampi JVB, Croda MG, Gonçalves CCM, Demarchi LHF, Croda J, Andrews JR. medRxiv. 2025 Sep 2; 2025 Sep 2. PMID: 40950492.
• Quantifying disruptions to tuberculosis case detection in Brazilian states during the COVID-19 pandemic.Chitwood MH, Menzies NA, Bartholomay P, Pelissari DM, Nildo de Barros Silva Júnior J, Harada LO, Johansen FDC, Maciel ELN, Castro MC, Sanchez M, Warren JL, Cohen T. Int J Epidemiol. 2025 Aug 18. PMID: 40838691.
• Using risk prediction models to inform personalized, cost-effective treatment recommendations.Neves MR, Franke M, Mitnick C, Ciobanu N, Crudu V, Furin J, Cohen T, Yaesoubi R. medRxiv. 2025 Aug 11; 2025 Aug 11. PMID: 40832389.
• Integrating genomic and spatial analyses to describe tuberculosis transmission: a scoping review.Lan Y, Rancu I, Chitwood MH, Sobkowiak B, Nyhan K, Lin HH, Wu CY, Mathema B, Brown TS, Colijn C, Warren JL, Cohen T. Lancet Microbe. 2025 Aug; 2025 Apr 11. PMID: 40228509.
• Implications of progressive lung damage and post-tuberculosis sequelae for the health benefits of prompt tuberculosis treatment in high HIV prevalence settings: a mathematical modelling analysis.Can MH, Sweeney S, Allwood BW, Dorman SE, Cohen T, Menzies NA. Lancet Glob Health. 2025 Jul. PMID: 40580989.
• Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States.Swartwood NA, Haddad MB, Marks SM, Beeler Asay GR, Horsburgh CR Jr, Cohen T, Menzies NA. Value Health. 2025 Jul; 2025 Apr 10. PMID: 40220866.
• High Mortality Rates Among Individuals Misdiagnosed With Tuberculosis: A Matched Retrospective Cohort Study of Individuals Diagnosed With Tuberculosis in Brazil.Thompson RR, Kim S, Pelissari DM, Harada LO, de Barros Silva JN Jr, Oliveira PB, Castro MC, Cohen T, Menzies NA. J Infect Dis. 2025 Jun 2. PMID: 39468776.
• Contribution of Posttuberculosis Sequelae to Life-Years Lost from Tuberculosis Disease in the United States, 2015-2019.Menzies NA, Marks SM, Hsieh YL, Swartwood NA, Beeler Asay GR, Skarbinski J, Horsburgh CR, Cohen T. Am J Respir Crit Care Med. 2025 Jun. PMID: 39928299.
• Classification of unsequenced Mycobacterium tuberculosis strains in a high-burden setting using a pairwise logistic regression approach.Rancu I, Sobkowiak B, Warren JL, Ciobanu N, Codreanu A, Crudu V, Colijn C, Cohen T, Chitwood MH. Access Microbiol. 2025; 2025 May 12. PMID: 40519974.
• Cost-effectiveness of screening with transcriptional signatures for incipient TB among U.S. migrants.Hsieh YL, Horsburgh CR Jr, Cohen T, Miller JW, Salomon JA, Menzies NA. PLoS Med. 2025 May; 2025 May 8. PMID: 40338978.
• Long-term mortality trends among individuals with tuberculosis: a retrospective cohort study of individuals diagnosed with tuberculosis in Brazil.Kim S, Pelissari DM, Harada LO, Sanchez M, Oliveira PB, Johansen FDC, Maciel ELN, Cohen T, Castro MC, Menzies NA. Clin Infect Dis. 2025 Apr 18; 2025 Apr 18. PMID: 40249758.
• Distribution and transmission of M. tuberculosis in a high-HIV prevalence city in Malawi: A genomic and spatial analysis.Chitwood MH, Corbett EL, Ndhlovu V, Sobkowiak B, Colijn C, Andrews JR, Burke RM, Cudahy PGT, Dodd PJ, Imai-Eaton JW, Engelthaler DM, Folkerts M, Feasey HRA, Lan Y, Lewis J, McNichol J, Menzies NA, Chipungu G, Nliwasa M, Weinberger DM, Warren JL, Salomon JA, MacPherson P, Cohen T. PLOS Glob Public Health. 2025; 2025 Apr 2. PMID: 40173177.
• Effectiveness and Cost-Effectiveness of Expanded Targeted Testing and Treatment of Latent Tuberculosis Infection Among the Medicare Population in 2022.Li Y, Marks SM, Beeler Asay GR, Winston CA, Pepin D, McClure S, Swartwood NA, Cohen T, Horsburgh CR Jr, Salomon JA, Menzies NA. Ann Intern Med. 2025 Apr; 2025 Feb 7. PMID: 39918348.
• Effects of the COVID-19 pandemic on TB outcomes in the United States: a Bayesian analysis.Swartwood NA, Cohen T, Marks SM, Hill AN, Beeler Asay GR, Self J, Feng PI, Horsburgh CR Jr, Salomon JA, Menzies NA. Clin Infect Dis. 2025 Feb 27; 2025 Feb 27. PMID: 40036593.
• A new method for detecting mixed Mycobacterium tuberculosis infection and reconstructing constituent strains provides insights into transmission.Sobkowiak B, Cudahy P, Chitwood MH, Clark TG, Colijn C, Grandjean L, Walter KS, Crudu V, Cohen T. Genome Med. 2025 Jan 27; 2025 Jan 27. PMID: 39871355.
• Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: An individual patient data meta-analysis.Kim S, Can MH, Agizew TB, Auld AF, Balcells ME, Bjerrum S, Dheda K, Dorman SE, Esmail A, Fielding K, Garcia-Basteiro AL, Hanrahan CF, Kebede W, Kohli M, Luetkemeyer AF, Mita C, Reeve BWP, Silva DR, Sweeney S, Theron G, Trajman A, Vassall A, Warren JL, Yotebieng M, Cohen T, Menzies NA. PLoS Med. 2025 Jan; 2025 Jan 13. PMID: 39804959.
• Signatures of transmission in within-host Mycobacterium tuberculosis complex variation: a retrospective genomic epidemiology study.Walter KS, Cohen T, Mathema B, Colijn C, Sobkowiak B, Comas I, Goig GA, Croda J, Andrews JR. Lancet Microbe. 2025 Jan; 2024 Nov 28. PMID: 39615498.
• Surveillance for TB drug resistance using routine rapid diagnostic testing data: Methodological development and application in Brazil.Baum SE, Pelissari DM, Dockhorn Costa F, Harada LO, Sanchez M, Bartholomay P, Cohen T, Castro MC, Menzies NA. PLoS Comput Biol. 2024 Dec; 2024 Dec 23. PMID: 39715258.
• Tiled Amplicon Sequencing Enables Culture-free Whole-Genome Sequencing of Pathogenic Bacteria From Clinical Specimens.Kalinich CC, Gonzalez FL, Osmaston A, Breban MI, Distefano I, Leon C, Sheen P, Zimic M, Coronel J, Tan G, Crudu V, Ciobanu N, Codreanu A, Solano W, Ráez J, Allicock OM, Chaguza C, Wyllie AL, Brandt M, Weinberger DM, Sobkowiak B, Cohen T, Grandjean L, Grubaugh ND, Redmond SN. bioRxiv. 2024 Dec 20; 2024 Dec 20. PMID: 39763738.
• Mass incarceration as a driver of the tuberculosis epidemic in Latin America and projected effects of policy alternatives: a mathematical modelling study.Liu YE, Mabene Y, Camelo S, Rueda ZV, Pelissari DM, Dockhorn Costa Johansen F, Huaman MA, Avalos-Cruz T, Alarcón VA, Ladutke LM, Bergman M, Cohen T, Goldhaber-Fiebert JD, Croda J, Andrews JR. Lancet Public Health. 2024 Nov; 2024 Oct 15. PMID: 39419058.
• Author Correction: The recent rapid expansion of multidrug resistant Ural lineage Mycobacterium tuberculosis in Moldova.Chitwood MH, Colijn C, Yang C, Crudu V, Ciobanu N, Codreanu A, Kim J, Rancu I, Rhee K, Cohen T, Sobkowiak B. Nat Commun. 2024 Oct 29; 2024 Oct 29. PMID: 39472436.
• Effects of the COVID-19 pandemic on TB outcomes in the United States: a Bayesian analysis.Swartwood NA, Cohen T, Marks SM, Hill AN, Asay GRB, Self J, Feng PI, Horsburgh CR Jr, Salomon JA, Menzies NA. medRxiv. 2024 Oct 18; 2024 Oct 18. PMID: 39484245.
• Cost-effectiveness of screening with transcriptional signatures for incipient TB among U.S. migrants.Hsieh YL, Horsburgh CR Jr, Cohen T, Miller JW, Salomon JA, Menzies NA. medRxiv. 2024 Oct 9; 2024 Oct 9. PMID: 39417109.
• Projected health and economic effects of a pan-tuberculosis treatment regimen: a modelling study.Ryckman TS, McQuaid CF, Cohen T, Menzies NA, Kendall EA. Lancet Glob Health. 2024 Oct; 2024 Aug 16. PMID: 39159654.
• Approaches for Mycobacterium tuberculosis Transmission Inference Based on Genomic Data.Cohen T, Colijn C, Warren JL. Am J Respir Crit Care Med. 2024 Sep 15. PMID: 39018565.
• Estimated Health and Economic Outcomes of Racial and Ethnic Tuberculosis Disparities in US-Born Persons.Swartwood NA, Li Y, Regan M, Marks SM, Barham T, Beeler Asay GR, Cohen T, Hill AN, Horsburgh CR Jr, Khan AD, McCree DH, Myles RL, Salomon JA, Self JL, Menzies NA. JAMA Netw Open. 2024 Sep 3; 2024 Sep 3. PMID: 39254977.
• Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study.van Lieshout Titan A, Klaassen F, Pelissari DM, de Barros Silva JN Júnior, Alves K, Alves LC, Sanchez M, Bartholomay P, Johansen FDC, Croda J, Andrews JR, Castro MC, Cohen T, Vuik C, Menzies NA. Lancet Glob Health. 2024 Sep. PMID: 39151980.
• The impact of COVID-19 national lockdowns on drug-resistant tuberculosis in KwaZulu-Natal, South Africa: A spatial analysis.Harrington KRV, Gandhi NR, Shah NS, Naidoo K, Auld SC, Andrews JR, Brust JCM, Lutchminarain K, Coe M, Willis F, Campbell A, Cohen T, Jenness SM, Waller LA. Ann Epidemiol. 2024 Sep; 2024 Jul 20. PMID: 39038747.
• Implications of progressive lung damage and post-TB sequelae for the health benefits of prompt TB diagnosis in high HIV prevalence settings: a mathematical modeling analysis.Can MH, Sweeney S, Allwood BW, Dorman SE, Cohen T, Menzies NA. medRxiv. 2024 Aug 17; 2024 Aug 17. PMID: 39185536.
• Molecular Epidemiology of Isoniazid-resistant M tuberculosis in Port-au-Prince, Haiti.Walsh KF, Lee MH, Chaguza C, Pamphile W, Royal G, Escuyer V, Pape JW, Fitzgerald D, Cohen T, Ocheretina O. Open Forum Infect Dis. 2024 Aug; 2024 Jul 18. PMID: 39119477.
• The long-term effects of domestic and international tuberculosis service improvements on tuberculosis trends within the USA: a mathematical modelling study.Menzies NA, Swartwood NA, Cohen T, Marks SM, Maloney SA, Chappelle C, Miller JW, Beeler Asay GR, Date AA, Horsburgh CR, Salomon JA. Lancet Public Health. 2024 Aug. PMID: 39095134.
• Risk factors underlying racial and ethnic disparities in tuberculosis diagnosis and treatment outcomes, 2011-19: a multiple mediation analysis of national surveillance data.Regan M, Barham T, Li Y, Swartwood NA, Beeler Asay GR, Cohen T, Horsburgh CR Jr, Khan A, Marks SM, Myles RL, Salomon JA, Self JL, Winston CA, Menzies NA. Lancet Public Health. 2024 Aug. PMID: 39095133.
• Phylogeographic Analysis of Mycobacterium kansasii Isolates from Patients with M. kansasii Lung Disease in Industrialized City, Taiwan.Tobias Cudahy PG, Liu PC, Warren JL, Sobkowiak B, Yang C, Ioerger TR, Wu CY, Lu PL, Wang JY, Chang HH, Huang HL, Cohen T, Lin HH. Emerg Infect Dis. 2024 Aug. PMID: 39043390.
• Potential of Pan-Tuberculosis Treatment to Drive Emergence of Novel Resistance.McQuaid CF, Ryckman TS, Menzies NA, White RG, Cohen T, Kendall EA. Emerg Infect Dis. 2024 Aug. PMID: 39043388.
• Uncertainty in tuberculosis clinical decision-making: An umbrella review with systematic methods and thematic analysis.Basile FW, Sweeney S, Singh MP, Bijker EM, Cohen T, Menzies NA, Vassall A, Indravudh P. PLOS Glob Public Health. 2024; 2024 Jul 23. PMID: 39042611.
• Mass incarceration as a driver of the tuberculosis epidemic in Latin America and projected impacts of policy alternatives: A mathematical modeling study.Liu YE, Mabene Y, Camelo S, Rueda ZV, Pelissari DM, Johansen FDC, Huaman MA, Avalos-Cruz T, Alarcón VA, Ladutke LM, Bergman M, Cohen T, Goldhaber-Fiebert JD, Croda J, Andrews JR. medRxiv. 2024 Jul 22; 2024 Jul 22. PMID: 39108530.
• e3SIM: epidemiological-ecological-evolutionary simulation framework for genomic epidemiology.Xu P, Liang S, Hahn A, Zhao V, Lo WT', Haller BC, Sobkowiak B, Chitwood MH, Colijn C, Cohen T, Rhee KY, Messer PW, Wells MT, Clark AG, Kim J. bioRxiv. 2024 Jul 2; 2024 Jul 2. PMID: 39005464.
• Corrigendum to-"Identifying local foci of tuberculosis transmission in Moldova using a spatial multinomial logistic regression model" [eBioMedicine 102(2024) 105085].Lan Y, Crudu V, Ciobanu N, Codreanu A, Chitwood MH, Sobkowiak B, Warren JL, Cohen T. EBioMedicine. 2024 Jul; 2024 Jun 28. PMID: 38943727.
• Predictors of unsuccessful tuberculosis treatment outcomes in Brazil: an analysis of 259,484 patient records.Ryuk DK, Pelissari DM, Alves K, Oliveira PB, Castro MC, Cohen T, Sanchez M, Menzies NA. BMC Infect Dis. 2024 May 27; 2024 May 27. PMID: 38802744.
• Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis.James LP, Klaassen F, Sweeney S, Furin J, Franke MF, Yaesoubi R, Chesov D, Ciobanu N, Codreanu A, Crudu V, Cohen T, Menzies NA. PLoS Med. 2024 May; 2024 May 3. PMID: 38701084.
• Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: an individual patient data meta-analysis.Kim S, Can MH, Agizew TB, Auld AF, Balcells ME, Bjerrum S, Dheda K, Dorman SE, Esmail A, Fielding K, Garcia-Basteiro AL, Hanrahan CF, Kebede W, Kohli M, Luetkemeyer AF, Mita C, Reeve BWP, Silva DR, Sweeney S, Theron G, Trajman A, Vassall A, Warren JL, Yotebieng M, Cohen T, Menzies NA. medRxiv. 2024 Apr 8; 2024 Apr 8. PMID: 38645191.
• The recent rapid expansion of multidrug resistant Ural lineage Mycobacterium tuberculosis in Moldova.Chitwood MH, Colijn C, Yang C, Crudu V, Ciobanu N, Codreanu A, Kim J, Rancu I, Rhee K, Cohen T, Sobkowiak B. Nat Commun. 2024 Apr 5; 2024 Apr 5. PMID: 38580642.
• Disparities in Tuberculosis Incidence by Race and Ethnicity Among the U.S.-Born Population in the United States, 2011 to 2021 : An Analysis of National Disease Registry Data.Li Y, Regan M, Swartwood NA, Barham T, Beeler Asay GR, Cohen T, Hill AN, Horsburgh CR Jr, Khan A, Marks SM, Myles RL, Salomon JA, Self JL, Menzies NA. Ann Intern Med. 2024 Apr; 2024 Apr 2. PMID: 38560914.
• Identifying local foci of tuberculosis transmission in Moldova using a spatial multinomial logistic regression model.Lan Y, Crudu V, Ciobanu N, Codreanu A, Chitwood MH, Sobkowiak B, Warren JL, Cohen T. EBioMedicine. 2024 Apr; 2024 Mar 26. PMID: 38531172.
• Quantifying gaps in the tuberculosis care cascade in Brazil: A mathematical model study using national program data.Emani S, Alves K, Alves LC, da Silva DA, Oliveira PB, Castro MC, Cohen T, Couto RM, Sanchez M, Menzies NA. PLoS Med. 2024 Mar; 2024 Mar 21. PMID: 38512968.
• Estimated rates of progression to tuberculosis disease for persons infected with Mycobacterium tuberculosis in the United States.Ekramnia M, Li Y, Haddad MB, Marks SM, Kammerer JS, Swartwood NA, Cohen T, Miller JW, Horsburgh CR, Salomon JA, Menzies NA. Epidemiology. 2024 Mar 1; 2023 Jan 30. PMID: 38290139.
• Racial and ethnic disparities in diagnosis and treatment outcomes among US-born people diagnosed with tuberculosis, 2003-19: an analysis of national surveillance data.Regan M, Li Y, Swartwood NA, Barham T, Asay GRB, Cohen T, Hill AN, Horsburgh CR, Khan A, Marks SM, Myles RL, Salomon JA, Self JL, Menzies NA. Lancet Public Health. 2024 Jan. PMID: 38176842.
• Signatures of transmission in within-host M. tuberculosis variation.Walter KS, Cohen T, Mathema B, Colijn C, Sobkowiak B, Comas I, Goig GA, Croda J, Andrews JR. medRxiv. 2023 Dec 29; 2023 Dec 29. PMID: 38234741.
• Spatial modeling of Mycobacterium tuberculosis transmission with dyadic genetic relatedness data.Warren JL, Chitwood MH, Sobkowiak B, Colijn C, Cohen T. Biometrics. 2023 Dec; 2023 Feb 15. PMID: 36745619.
• Spatially-targeted tuberculosis screening has limited impact beyond household contact tracing in Lima, Peru: A model-based analysis.Havumaki J, Warren JL, Zelner J, Menzies NA, Calderon R, Contreras C, Lecca L, Becerra MC, Murray M, Cohen T. PLoS One. 2023; 2023 Oct 30. PMID: 37903091.
• Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis.Menzies NA, Allwood BW, Dean AS, Dodd PJ, Houben RMGJ, James LP, Knight GM, Meghji J, Nguyen LN, Rachow A, Schumacher SG, Mirzayev F, Cohen T. Nat Commun. 2023 Oct 4; 2023 Oct 4. PMID: 37794037.
• Tabby2: a user-friendly web tool for forecasting state-level TB outcomes in the United States.Swartwood NA, Testa C, Cohen T, Marks SM, Hill AN, Beeler Asay G, Cochran J, Cranston K, Randall LM, Tibbs A, Horsburgh CR Jr, Salomon JA, Menzies NA. BMC Med. 2023 Aug 30; 2023 Aug 30. PMID: 37649031.
• Changes in Population Immunity Against Infection and Severe Disease From Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variants in the United States Between December 2021 and November 2022.Klaassen F, Chitwood MH, Cohen T, Pitzer VE, Russi M, Swartwood NA, Salomon JA, Menzies NA. Clin Infect Dis. 2023 Aug 14. PMID: 37074868.
• Global, regional, and national estimates of tuberculosis incidence and case detection among incarcerated individuals from 2000 to 2019: a systematic analysis.Martinez L, Warren JL, Harries AD, Croda J, Espinal MA, Olarte RAL, Avedillo P, Lienhardt C, Bhatia V, Liu Q, Chakaya J, Denholm JT, Lin Y, Kawatsu L, Zhu L, Horsburgh CR, Cohen T, Andrews JR. Lancet Public Health. 2023 Jul. PMID: 37393090.
• Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual participant data meta-analysis.Gunasekera KS, Marcy O, Muñoz J, Lopez-Varela E, Sekadde MP, Franke MF, Bonnet M, Ahmed S, Amanullah F, Anwar A, Augusto O, Aurilio RB, Banu S, Batool I, Brands A, Cain KP, Carratalá-Castro L, Caws M, Click ES, Cranmer LM, García-Basteiro AL, Hesseling AC, Huynh J, Kabir S, Lecca L, Mandalakas A, Mavhunga F, Myint AA, Myo K, Nampijja D, Nicol MP, Orikiriza P, Palmer M, Sant'Anna CC, Siddiqui SA, Smith JP, Song R, Thuong Thuong NT, Ung V, van der Zalm MM, Verkuijl S, Viney K, Walters EG, Warren JL, Zar HJ, Marais BJ, Graham SM, Debray TPA, Cohen T, Seddon JA. Lancet Child Adolesc Health. 2023 May; 2023 Mar 13. PMID: 36924781.
• Transmission modeling to infer tuberculosis incidence prevalence and mortality in settings with generalized HIV epidemics.Dodd PJ, Shaweno D, Ku CC, Glaziou P, Pretorius C, Hayes RJ, MacPherson P, Cohen T, Ayles H. Nat Commun. 2023 Mar 24; 2023 Mar 24. PMID: 36964130.
• Quantifying Mycobacterium tuberculosis Transmission Dynamics Across Global Settings: A Systematic Analysis.Smith JP, Cohen T, Dowdy D, Shrestha S, Gandhi NR, Hill AN. Am J Epidemiol. 2023 Jan 6. PMID: 36227246.
• Re-evaluating the health impact and cost-effectiveness of tuberculosis preventive treatment for modern HIV cohorts on antiretroviral therapy: a modelling analysis using data from Tanzania.Zhu J, Lyatuu G, Sudfeld CR, Kiravu A, Sando D, Machumi L, Minde J, Chisonjela F, Cohen T, Menzies NA. Lancet Glob Health. 2022 Nov. PMID: 36240830.
• Budget impact of next-generation sequencing for diagnosis of TB drug resistance in Moldova.Cates L, Codreanu A, Ciobanu N, Fosburgh H, Allender CJ, Centner H, Engelthaler DM, Crudu V, Cohen T, Menzies NA. Int J Tuberc Lung Dis. 2022 Oct 1. PMID: 36163669.
• Excess tuberculosis cases and deaths following an economic recession in Brazil: an analysis of nationally representative disease registry data.Li Y, de Macedo Couto R, Pelissari DM, Costa Alves L, Bartholomay P, Maciel EL, Sanchez M, Castro MC, Cohen T, Menzies NA. Lancet Glob Health. 2022 Oct; 2022 Aug 29. PMID: 36049488.
• A spatial-mechanistic model to estimate subnational tuberculosis burden with routinely collected data: An application in Brazilian municipalities.Chitwood MH, Alves LC, Bartholomay P, Couto RM, Sanchez M, Castro MC, Cohen T, Menzies NA. PLOS Glob Public Health. 2022; 2022 Sep 21. PMID: 36962578.
• National survey in South Africa reveals high tuberculosis prevalence among previously treated people.Marx FM, Hesseling AC, Martinson N, Theron G, Cohen T. Lancet Infect Dis. 2022 Sep. PMID: 36029778.
• Neighbourhood prevalence-to-notification ratios for adult bacteriologically-confirmed tuberculosis reveals hotspots of underdiagnosis in Blantyre, Malawi.Khundi M, Carpenter JR, Corbett EL, Feasey HRA, Soko RN, Nliwasa M, Twabi H, Chiume L, Burke RM, Horton KC, Dodd PJ, Cohen T, MacPherson P. PLoS One. 2022; 2022 May 23. PMID: 35605004.
• Trends, Mechanisms, and Racial/Ethnic Differences of Tuberculosis Incidence in the US-Born Population Aged 50 Years or Older in the United States.Kim S, Cohen T, Horsburgh CR, Miller JW, Hill AN, Marks SM, Li R, Kammerer JS, Salomon JA, Menzies NA. Clin Infect Dis. 2022 May 3. PMID: 34323959.
• The role of prisons in disseminating tuberculosis in Brazil: A genomic epidemiology study.Walter KS, Dos Santos PCP, Gonçalves TO, da Silva BO, da Silva Santos A, de Cássia Leite A, da Silva AM, Figueira Moreira FM, de Oliveira RD, Lemos EF, Cunha E, Liu YE, Ko AI, Colijn C, Cohen T, Mathema B, Croda J, Andrews JR. Lancet Reg Health Am. 2022 May; 2022 Feb 1. PMID: 35647574.
• Spatially targeted digital chest radiography to reduce tuberculosis in high-burden settings: A study of adaptive decision making.de Villiers AK, Dye C, Yaesoubi R, Cohen T, Marx FM. Epidemics. 2022 Mar; 2022 Jan 21. PMID: 35093849.
• A Cluster-based Method to Quantify Individual Heterogeneity in Tuberculosis Transmission.Smith JP, Gandhi NR, Silk BJ, Cohen T, Lopman B, Raz K, Winglee K, Kammerer S, Benkeser D, Kramer MR, Hill AN. Epidemiology. 2022 Mar 1. PMID: 34907974.
• Phylogeography and transmission of M. tuberculosis in Moldova: A prospective genomic analysis.Yang C, Sobkowiak B, Naidu V, Codreanu A, Ciobanu N, Gunasekera KS, Chitwood MH, Alexandru S, Bivol S, Russi M, Havumaki J, Cudahy P, Fosburgh H, Allender CJ, Centner H, Engelthaler DM, Menzies NA, Warren JL, Crudu V, Colijn C, Cohen T. PLoS Med. 2022 Feb; 2022 Feb 22. PMID: 35192619.
• Global estimates of paediatric tuberculosis incidence in 2013-19: a mathematical modelling analysis.Yerramsetti S, Cohen T, Atun R, Menzies NA. Lancet Glob Health. 2022 Feb; 2021 Dec 8. PMID: 34895517.
• vCOMBAT: a novel tool to create and visualize a computational model of bacterial antibiotic target-binding.Tran VN, Shams A, Ascioglu S, Martinecz A, Liang J, Clarelli F, Mostowy R, Cohen T, Abel Zur Wiesch P. BMC Bioinformatics. 2022 Jan 6; 2022 Jan 6. PMID: 34991453.
• Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis using machine learning methods.You S, Chitwood MH, Gunasekera KS, Crudu V, Codreanu A, Ciobanu N, Furin J, Cohen T, Warren JL, Yaesoubi R. PLOS Digit Health. 2022; 2022 Jun 30. PMID: 36177394.
• The Health and Economic Benefits of Tests That Predict Future Progression to Tuberculosis Disease.Menzies NA, Shrestha S, Parriott A, Marks SM, Hill AN, Dowdy DW, Shete PB, Cohen T, Salomon JA. Epidemiology. 2022 Jan 1. PMID: 34669631.
• Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae.Menzies NA, Quaife M, Allwood BW, Byrne AL, Coussens AK, Harries AD, Marx FM, Meghji J, Pedrazzoli D, Salomon JA, Sweeney S, van Kampen SC, Wallis RS, Houben RMGJ, Cohen T. Lancet Glob Health. 2021 Dec. PMID: 34798027.
• Development of a Treatment-decision Algorithm for Human Immunodeficiency Virus-uninfected Children Evaluated for Pulmonary Tuberculosis.Gunasekera KS, Walters E, van der Zalm MM, Palmer M, Warren JL, Hesseling AC, Cohen T, Seddon JA. Clin Infect Dis. 2021 Aug 16. PMID: 33449999.
• Evolution and emergence of multidrug-resistant Mycobacterium tuberculosis in Chisinau, Moldova.Brown TS, Eldholm V, Brynildsrud O, Osnes M, Levy N, Stimson J, Colijn C, Alexandru S, Noroc E, Ciobanu N, Crudu V, Cohen T, Mathema B. Microb Genom. 2021 Aug. PMID: 34431762.
• Effectiveness of spatially targeted interventions for control of HIV, tuberculosis, leprosy and malaria: a systematic review.Khundi M, Carpenter JR, Nliwasa M, Cohen T, Corbett EL, MacPherson P. BMJ Open. 2021 Jul 13; 2021 Jul 13. PMID: 34257091.
• Understanding the Host in the Management of Pneumonia. An Official American Thoracic Society Workshop Report.Dela Cruz CS, Evans SE, Restrepo MI, Dean N, Torres A, Amara-Elori I, Awasthi S, Caler E, Cao B, Chalmers JD, Chastre J, Cohen TS, Cohen AH, Crothers K, Di YP, Egan ME, Feldman C, Gautam S, Halstead ES, Herold S, Jones BE, Luna C, Niederman MS, Mendez R, Menendez R, Mizgerd JP, Nusrat R, Ramirez J, Shindo Y, Waterer G, Yeligar SM, Wunderink RG. Ann Am Thorac Soc. 2021 Jul. PMID: 34242148.
• The impact of COVID-19 on TB: a review of the data.McQuaid CF, Vassall A, Cohen T, Fiekert K, White RG. Int J Tuberc Lung Dis. 2021 Jun 1. PMID: 34049605.
• Bayesian evidence synthesis to estimate subnational TB incidence: An application in Brazil.Chitwood MH, Pelissari DM, Drummond Marques da Silva G, Bartholomay P, Rocha MS, Sanchez M, Arakaki-Sanchez D, Glaziou P, Cohen T, Castro MC, Menzies NA. Epidemics. 2021 Jun; 2021 Feb 20. PMID: 33676092.
• Incidence and prevalence of tuberculosis in incarcerated populations: a systematic review and meta-analysis.Cords O, Martinez L, Warren JL, O'Marr JM, Walter KS, Cohen T, Zheng J, Ko AI, Croda J, Andrews JR. Lancet Public Health. 2021 May; 2021 Mar 22. PMID: 33765455.
• The escalating tuberculosis crisis in central and South American prisons.Walter KS, Martinez L, Arakaki-Sanchez D, Sequera VG, Estigarribia Sanabria G, Cohen T, Ko AI, García-Basteiro AL, Rueda ZV, López-Olarte RA, Espinal MA, Croda J, Andrews JR. Lancet. 2021 Apr 24; 2021 Apr 8. PMID: 33838724.
• The positive externalities of migrant-based TB control strategy in a Chinese urban population with internal migration: a transmission-dynamic modeling study.Yang C, Kang J, Lu L, Guo X, Shen X, Cohen T, Menzies NA. BMC Med. 2021 Apr 20; 2021 Apr 20. PMID: 33874940.
• Reporting practices for genomic epidemiology of tuberculosis: a systematic review of the literature using STROME-ID guidelines as a benchmark.Cheng B, Behr MA, Howden BP, Cohen T, Lee RS. Lancet Microbe. 2021 Mar; 2021 Mar 2. PMID: 33842904.
• Laboratory costs of diagnosing TB in a high multidrug-resistant TB setting.Cates L, Crudu V, Codreanu A, Ciobanu N, Fosburgh H, Cohen T, Menzies NA. Int J Tuberc Lung Dis. 2021 Mar 1. PMID: 33688812.
• Trends in Untreated Tuberculosis in Large Municipalities, Brazil, 2008-2017.Chitwood MH, Pelissari DM, Marques da Silva GD, Bartholomay P, Rocha MS, Arakaki-Sanchez D, Sanchez M, Cohen T, Castro MC, Menzies NA. Emerg Infect Dis. 2021 Mar. PMID: 33622464.
• Yield, Efficiency, and Costs of Mass Screening Algorithms for Tuberculosis in Brazilian Prisons.Santos ADS, de Oliveira RD, Lemos EF, Lima F, Cohen T, Cords O, Martinez L, Gonçalves C, Ko A, Andrews JR, Croda J. Clin Infect Dis. 2021 Mar 1. PMID: 32064514.
• Protective impacts of household-based tuberculosis contact tracing are robust across endemic incidence levels and community contact patterns.Havumaki J, Cohen T, Zhai C, Miller JC, Guikema SD, Eisenberg MC, Zelner J. PLoS Comput Biol. 2021 Feb; 2021 Feb 8. PMID: 33556077.
• Ongoing challenges to understanding multidrug- and rifampicin-resistant tuberculosis in children versus adults.McQuaid CF, Cohen T, Dean AS, Houben RMGJ, Knight GM, Zignol M, White RG. Eur Respir J. 2021 Feb; 2021 Feb 4. PMID: 32855219.
• Continuity of TB services during the COVID-19 pandemic in China.Shen X, Sha W, Yang C, Pan Q, Cohen T, Cheng S, Cai Q, Kan X, Zong P, Zeng Z, Tan S, Liang R, Bai L, Xia J, Wu S, Sun P, Wu G, Cai C, Wang X, Ai K, Liu J, Yuan Z. Int J Tuberc Lung Dis. 2021 Jan 1. PMID: 33384053.
• Time Since Infection and Risks of Future Disease for Individuals with Mycobacterium tuberculosis Infection in the United States.Menzies NA, Swartwood N, Testa C, Malyuta Y, Hill AN, Marks SM, Cohen T, Salomon JA. Epidemiology. 2021 Jan. PMID: 33009253.
• Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi.Hsieh YL, Jahn A, Menzies NA, Yaesoubi R, Salomon JA, Girma B, Gunde L, Eaton JW, Auld A, Odo M, Kiyiika CN, Kalua T, Chiwandira B, Mpunga JU, Mbendra K, Corbett L, Hosseinipour MC, Cohen T, Kunkel A. J Acquir Immune Defic Syndr. 2020 Dec 15. PMID: 33177475.
• High-resolution estimates of tuberculosis incidence among non-U.S.-born persons residing in the United States, 2000-2016.Hill AN, Cohen T, Salomon JA, Menzies NA. Epidemics. 2020 Dec; 2020 Nov 10. PMID: 33242759.
• Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States.Menzies NA, Bellerose M, Testa C, Swartwood NA, Malyuta Y, Cohen T, Marks SM, Hill AN, Date AA, Maloney SA, Bowden SE, Grills AW, Salomon JA. Am J Respir Crit Care Med. 2020 Dec 1. PMID: 32645277.
• Risk factors for recurrent tuberculosis after successful treatment in a high burden setting: a cohort study.Cudahy PGT, Wilson D, Cohen T. BMC Infect Dis. 2020 Oct 23; 2020 Oct 23. PMID: 33097000.
• Children as sentinels of tuberculosis transmission: disease mapping of programmatic data.Gunasekera KS, Zelner J, Becerra MC, Contreras C, Franke MF, Lecca L, Murray MB, Warren JL, Cohen T. BMC Med. 2020 Sep 2; 2020 Sep 2. PMID: 32873309.
• Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis.Marx FM, Cohen T, Menzies NA, Salomon JA, Theron G, Yaesoubi R. Lancet Glob Health. 2020 Sep. PMID: 32827484.